Showing results (151-160 of 270) with videos related to
Sort By:
Pageof 27
Annals of Vascular Surgery|February 9, 2020
Timing of Thoracic Outlet Decompression after Thrombolysis for Primary Upper Extremity Deep Venous Thrombosis: A Systematic ReviewRobert J C M F de Kleijn, Ludo Schropp, Jan Westerink, et al.European Journal of Clinical Investigation|February 13, 2013
Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposityDaniël R Faber, Yolanda van der Graaf, Jan Westerink, et al.Diabetes Care|August 17, 2019
Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD TrialTamar I de Vries, Jannick A N Dorresteijn, Yolanda van der Graaf, et al.Journal of Hypertension|March 2, 2006
Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in menMehran Firouzi, Bart Kok, Wilko Spiering, et al.Nederlands Tijdschrift Voor Geneeskunde|September 10, 2025
[Sex differences in the pharmacological treatment of hypertension in primary care]Elisa Dal Canto, Sophie L Theunisse, Michiel L Bots, et al.Diabetes, Obesity & Metabolism|November 4, 2016
Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetesSanne N van Munster, Yolanda van der Graaf, Harold W de Valk, et al.Diabetes Care|February 24, 2018
Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 DiabetesCharlotte Koopal, Frank L J Visseren, Jan Westerink, et al.The American Journal of Cardiology|January 3, 2015
Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular diseaseAnton P van de Woestijne, Yolanda van der Graaf, Jan Westerink, et al.Cardiovascular Diabetology|October 18, 2017
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trialsMarit de Jong, H Bart van der Worp, Yolanda van der Graaf, et al.Journal of Hypertension|June 8, 2018
Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular diseaseMonique E A M van Kleef, Frank L J Visseren, Joris W P Vernooij, et al.Pageof 27